ACINETOCLINIC
31 jul. 14
ACINETOCLINIC Transition to Clinical Investigation Phase for Licencing of the First Vaccine Against Drug Resistent Acinetobacter Baumannii ABSTRACT Vaccines against
ACINETOCLINIC Transition to Clinical Investigation Phase for Licencing of the First Vaccine Against Drug Resistent Acinetobacter Baumannii ABSTRACT Vaccines against
IDP4MM Development of drugs in new therapeutic IDP targets for the treatment of multiple myeloma ABSTRACT This project is part
TOXAB Development of Novel, Safe and Affordable Cytotoxic Antibodies for the Treatment of Cancer ABSTRACT The main objective of the
NUEVAS DIANAS Discovery and combination of new treatments for cancer treatment based on the modulation of epigenetic targets and adenosine
MICROALMABS Validation of a New Platform for Production of Therapeutic Monoclonal Antibodies with Microalgae ABSTRACT The objective of the present
METASTASIS Anti-tumor and anti-metastasis activity of monoclonal antibodies in animal models of human cancers ABSTRACT The limited effectiveness of approved
SMARTPRO Lightweight, flexible and smart protective clothing for law enforcement personnel smartpro-project.eu ABSTRACT The concept of SMARTPRO lies in the
STEP-2-SPORT STEP-by-STEP renovation towards nearly zero energy SPORT buildings step2sport.eu ABSTRACT STEP-2-SPORT project aims to support the refurbishment of the
FENTO3 Reduction of the environmental impact of industrial effluents and urban wastewater treatment plants www.fento3.com ABSTRACT The FENTO3 project develops
BANTEX Valorization of fibers extracted from banana plantation waste to obtain yarn, fabrics and composite materials. ABSTRACT The main objectives
BOATDIGEST Boat Dismantling Insight by Generating Environmental and Safety Training www.boatdigest.eu ABSTRACT The Boat Dismantling Insight by Generating Environmental and
Demonstrating integrated innovative technologies for an optimal and safe closed water cycle in Mediterranean tourist facilities
Cost-Effective sensors, interoperable with international existing ocean observing systems to meet EU policies.
Assessment and mitigation of nano-enabled product risks on human and environmental health: Development of new strategies and creation of a
Tel. (+34) 937 882 300
